Okabe Takashi, Ueno Hironori, Fujita Shinya, Kagoo Toshiya, Boku Saigen, Yano Takahiro, Yokoyama Akihiro
Division of Hematology, Department of Internal Medicine, National Hospital Organization Tokyo Medical Center.
Rinsho Ketsueki. 2018;59(8):1007-1011. doi: 10.11406/rinketsu.59.1007.
Acquired factor V (FV) inhibitor is a rare disorder. Herein we report a case of an 82-year-old Japanese woman with FV inhibitor exhibiting a pseudo decline in the activities of the multiple coagulation factors. After rectal cancer surgery, she received antibiotic therapy for wound infection. As prothrombin and activated partial thromboplastin time was prolonged, heparin for atrial fibrillation was discontinued without improvement. Coagulation factor activity assays revealed deficiencies in II, V, VII, VIII, IX, X, XI, and XII factor activities; in particular, the FV activity was markedly decreased to <1%. The cross-mixing test findings revealed an inhibitor pattern, and multiple coagulation factor inhibitors were positive. The FV inhibitor level was high at 62 Bethesda U/ml. The patient exhibited no bleeding tendency with the prolonged wound infection without immunosuppressive therapy. The inhibitor disappeared four months after the onset.
获得性因子V(FV)抑制剂是一种罕见的疾病。在此,我们报告一例82岁日本女性患有FV抑制剂,其多种凝血因子活性出现假性下降。直肠癌手术后,她因伤口感染接受了抗生素治疗。由于凝血酶原时间和活化部分凝血活酶时间延长,用于房颤的肝素停药后仍无改善。凝血因子活性测定显示II、V、VII、VIII、IX、X、XI和XII因子活性缺乏;特别是FV活性显著降低至<1%。交叉混合试验结果显示为抑制剂模式,多种凝血因子抑制剂呈阳性。FV抑制剂水平较高,为62 Bethesda单位/毫升。在伤口感染延长且未进行免疫抑制治疗的情况下,患者未表现出出血倾向。抑制剂在发病四个月后消失。